Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2025
Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin LymphomaSattva S Neelapu, Julio C Chavez, Alison R Sehgal, et al.
Annals of Internal Medicine|January 1, 2014
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceHarry J de Koning, Rafael Meza, Sylvia K Plevritis, et al.
Transplantation and Cellular Therapy|June 22, 2025
Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCTShatha Farhan, Vanessa E Kennedy, Manuel R Espinoza-Gutarra, et al.
Blood|October 25, 2023
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)Sattva S Neelapu, Julio C Chavez, Alison R Sehgal, et al.
The Lancet. Oncology|December 13, 2021
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trialCaron A Jacobson, Julio C Chavez, Alison R Sehgal, et al.
Diabetes Care|December 19, 2015
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 DiabetesRuth S Weinstock, Stephanie N DuBose, Richard M Bergenstal, et al.
Pageof 13